ATE318300T1 - Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe - Google Patents

Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe

Info

Publication number
ATE318300T1
ATE318300T1 AT98961344T AT98961344T ATE318300T1 AT E318300 T1 ATE318300 T1 AT E318300T1 AT 98961344 T AT98961344 T AT 98961344T AT 98961344 T AT98961344 T AT 98961344T AT E318300 T1 ATE318300 T1 AT E318300T1
Authority
AT
Austria
Prior art keywords
staphylococcus aureus
produced therefrom
isolated strains
vaccines produced
animal
Prior art date
Application number
AT98961344T
Other languages
English (en)
Inventor
Ze Ev Trainin
Gabriel Leitner
Eugenia Liubashewsky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE318300T1 publication Critical patent/ATE318300T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44Staphylococcus
    • C12R2001/445Staphylococcus aureus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT98961344T 1997-12-31 1998-12-29 Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe ATE318300T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12282997A IL122829A (en) 1997-12-31 1997-12-31 Isolated strains of staphylococcus aureus and vaccines manufactured therefrom

Publications (1)

Publication Number Publication Date
ATE318300T1 true ATE318300T1 (de) 2006-03-15

Family

ID=11071042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961344T ATE318300T1 (de) 1997-12-31 1998-12-29 Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe

Country Status (12)

Country Link
US (1) US6544529B1 (de)
EP (1) EP1042450B1 (de)
AT (1) ATE318300T1 (de)
AU (1) AU746285B2 (de)
BR (1) BR9814556A (de)
CA (1) CA2317092A1 (de)
DE (1) DE69833568T2 (de)
ES (1) ES2259218T3 (de)
IL (1) IL122829A (de)
NZ (1) NZ505194A (de)
PL (1) PL341541A1 (de)
WO (1) WO1999033954A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974573B2 (en) 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
US8268579B2 (en) * 2008-01-24 2012-09-18 Pilots Point Llc Method and medium for detecting the presence or absence of pathogenic staphylococci in a first generation test sample
EP2844275B1 (de) * 2012-04-26 2020-05-13 University of Chicago Staphylokokken-coagulase-antigene und verfahren zu deren verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
AU8592982A (en) * 1981-07-14 1983-01-20 Commonwealth Scientific And Industrial Research Organisation Mastitis vaccine
US4780307A (en) * 1984-10-23 1988-10-25 Rafa Laboratories Ltd. Aluminum hydroxide

Also Published As

Publication number Publication date
ES2259218T3 (es) 2006-09-16
IL122829A (en) 2000-06-29
IL122829A0 (en) 1998-08-16
WO1999033954A1 (en) 1999-07-08
DE69833568T2 (de) 2006-12-28
US6544529B1 (en) 2003-04-08
EP1042450A1 (de) 2000-10-11
AU1681199A (en) 1999-07-19
AU746285B2 (en) 2002-04-18
PL341541A1 (en) 2001-04-23
BR9814556A (pt) 2000-10-17
CA2317092A1 (en) 1999-07-08
DE69833568D1 (de) 2006-04-27
NZ505194A (en) 2001-12-21
EP1042450B1 (de) 2006-02-22

Similar Documents

Publication Publication Date Title
ATE461709T1 (de) Choline-bindende proteine derivate aus pneumokoken als impfstoff
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
DK0549617T3 (da) Forbedrede vaccinepræparater
BRPI0007936B8 (pt) composto, formulação adjuvante imunológica, e formulação de vacina.
DK0588578T3 (da) Immunogener
CA2022420A1 (en) Escherichia coli vaccine
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
ES2182914T3 (es) Inmunopotenciacion inducida de quitosan.
IL105119A0 (en) Immunoglobins and antigens for the treatment of staphylococcus infections,methods for the identification and preparation thereof and pharmaceutical compositions containing the same
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
ATE318300T1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
ATE285791T1 (de) Impfstoff, der acemannan als adjuvans enthält
FR2646776B1 (fr) Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
DK0623170T3 (da) Vacciner baseret på streptokinase
SU1538305A1 (ru) Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
MX9301736A (es) Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
WO2024130155A3 (en) Swine influenza vaccine compositions and methods thereof
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo
RO100738A2 (ro) Procedeu de preparare a vaccinului inactivat uleios, contra bursitei infectioase aviare

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties